From encircle study, during the procedure of a 29 mm sapien m3 valve in the mitral position via transfemoral approach, the valve was not inflated all the way due to use error.The operator unintentionally did not bottom out the atrion.No change on patient outcome.The valve was deployed and a post-dilation inflation adding 4 cc to atrion 4cc.The valve was implanted with great results.
|
The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was provided from the site and revealed the following: after balloon expansion, there appears to be a waist on valve.Valve appears to be fully expanded after post-dilation.A review of the risk management documentation was performed, and the reported event is an anticipated risk of the transcatheter heart valve procedure.No evidence of product non-conformances or labeling/ifu inadequacies were identified in the evaluation.The complaint was confirmed from imagery.The reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency.A review of the ifu and training manuals revealed no deficiencies.As reported, ''the valve was not inflated all the way due to use error.The operator unintentionally did not bottom out the atrion.No change on patient outcome.The valve was deployed and a post-dilation inflation adding 4 cc to atrion 4cc.The valve was implanted with great results.'' per ifu, ''deploy the valve by inflating the balloon with the entire volume in the inflation device, hold for 3 seconds, and confirm that the barrel of the inflation device is empty to ensure complete inflation of the balloon''.In this case, the valve or balloon was not fully inflated due to the operator not emptying the inflation device.As such, available information suggests procedural factors (operator did not use entire volume on inflation device) may have contributed to the reported event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
|